Holder plans sale of 230 ISRG shares under Rule 144

A shareholder of ISRG has filed a notice of proposed sale under Rule 144 to sell 230 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

A shareholder of ISRG has filed a notice of proposed sale under Rule 144 to sell 230 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares to be sold have an aggregate market value of $122,500.30, while 354,496,073 shares of the issuer’s common stock are reported as outstanding. The planned sale date is listed as 01/27/2026 on the NASDAQ market, and the shares were acquired on the same date via a stock option exercise paid in cash.

The filer also reports prior sales of the issuer’s common stock during the past three months, including a transaction on 10/28/2025 in which 7,562 shares were sold for $4,147,192.12 in gross proceeds. By signing, the seller represents that they are not aware of any material adverse, non‑public information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ISRG Rule 144 filing disclose about planned share sales?

The filing states that a shareholder plans to sell 230 shares of ISRG common stock with an aggregate market value of $122,500.30 on 01/27/2026 through Morgan Stanley Smith Barney LLC on the NASDAQ market.

How were the ISRG shares in this Rule 144 notice acquired?

The 230 ISRG common shares to be sold were acquired on 01/27/2026 via a stock option exercise from the issuer, with the purchase price paid in cash.

How many ISRG shares are reported as outstanding in the filing?

The notice reports that there are 354,496,073 shares of the issuer’s common stock outstanding at the time referenced in the form.

What recent ISRG share sales by the same seller are disclosed?

The document lists several sales over the past three months, including a sale on 10/28/2025 of 7,562 shares of ISRG common stock for $4,147,192.12 in gross proceeds.

What representation does the seller make in the ISRG Rule 144 notice?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned ISRG share sale under Rule 144?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the 230-share ISRG sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/27/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001632901
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INTUITIVE SURGICAL, INC.
SEC File Number	000-30713
Address of Issuer	1020 KIFER ROAD SUNNYVALE CALIFORNIA 94086
Phone	(408) 523-2100
Name of Person for Whose Account the Securities are To Be Sold	MYRIAM CURET MCADAMS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	230	122500.30	354496073	01/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2026	Stock Option Exercise	ISSUER			230	01/27/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	12/10/2025	104	58229.60
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	12/01/2025	125	71123.75
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	11/10/2025	105	58800.00
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	10/29/2025	125	67875.00
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	10/28/2025	7562	4147192.12

144: Remarks and Signature

Remarks
Date of Notice	01/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Myriam Curet McAdams
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)